Andrea Pirzkall
Nessuna posizione attualmente
Profilo
Andrea Pirzkall worked as the Chief Medical Director at Genentech, Inc. from 2007 to 2017.
She then worked as the Executive Director-Clinical Development at BeiGene Ltd.
from 2017 to 2020.
Prior to that, she was the Director-Clinical Affairs at DxTx Medical, Inc. from 2002 to 2003.
Most recently, she served as the Chief Medical Officer at Replimune Group, Inc. from 2020 to 2021.
Pirzkall earned a doctorate degree from Friedrich Schiller University of Jena.
Precedenti posizioni note di Andrea Pirzkall
| Società | Posizione | Fine |
|---|---|---|
| REPLIMUNE GROUP, INC. | Chief Tech/Sci/R&D Officer | 25/08/2021 |
| BEIGENE, LTD. | Chief Tech/Sci/R&D Officer | 01/07/2020 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/08/2017 |
| DxTx Medical, Inc. | Chief Tech/Sci/R&D Officer | 01/01/2003 |
Formazione di Andrea Pirzkall
| Friedrich Schiller University of Jena | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| REPLIMUNE GROUP, INC. | Health Technology |
| BEIGENE, LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| DxTx Medical, Inc. |
- Borsa valori
- Insiders
- Andrea Pirzkall
